... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Classification Diagnostic systems Psychiatry Psychosis Schizophrenia Diagnostic...

... to in the content or advertisements. Clozapine Obsessive-compulsive symptoms Adverse effects Schizophrenia Psychotherapy Comorbidity of schizophrenia and obsessive-compulsive symptoms (OCS) or obsessive-compulsive disorder (OCD) has received increasing attention over the past decade. The presence...

...Jérôme Favrod; Alexandra Nguyen; Joséphine Chaix; Joanie Pellet; Laurent Frobert; Caroline Fankhauser; Alban Ismailaj; Armando Brana; Gwennaïg Tamic; Caroline Suter; Shyhrete Rexhaj; Philippe Golay; Charles Bonsack Background: Negative symptoms are frequent in patients with schizophrenia...

..., and long-acting injectable risperidone, olanzapine, quetiapine, and aripiprazole). These studies show that the prevalence rates of SP remain high in schizophrenia (30%) and higher (70%) in treatment-resistant schizophrenia. We then present neurobehavioral findings on antipsychotic-induced supersensitivity...

... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Computer mediation Psychiatric treatment Quality of life Schizophrenia Treatment...

...Stavros Orfanos; Ciara Banks; Stefan Priebe Background: Different psychotherapeutic treatments for schizophrenia are delivered in groups. However, little is known about the effectiveness of these group therapies for people with schizophrenia across different treatments with varying therapeutic...

...-compulsive symptoms in schizophrenia: insight into pathomechanisms facilitates treatment. Adv Med 2014 (article ID 317980). 2. Cunill R, Castells X, Simeon D: Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: a systematic review and meta-analysis. J...

...Lorna Farquharson; Andrew K. MacLeod This study suggests that GAP could be an effective intervention for enhancing the well-being of people with schizophrenia and other psychiatric disorders, enhancing the existing evidence base for the clinical application of GAP. It also provides a potential...

... syndrome (DS), Huntington's disease (HD), multiple sclerosis (MS), Parkinson's disease (PD) and schizophrenia (SCZ). Method: Comprehensive search in PubMed/MEDLINE, Scopus and ISI Web of Knowledge of the literature published before March 2013. We identified 51 relevant articles from 2,229 discrete...

... in schizophrenia and affective disorders research during 2000-2010. Results: Among 2,467 publications, 61 (2.5%; 95% confidence interval: 1.9-3.1%) reported assessing participant, rater, or clinician blinding: 5/672 reports on schizophrenia (0.7%; 0.3-1.6%) and 33/1,079 (3.1%; 2.1-4.2%) on affective disorders...

... used: ‘stage/staging’ AND ‘psychiatric disorder/mental disorder/schizophrenia/mood disorder/anxiety disorder/substance use disorder/eating disorder’. Results: A total of 78 studies were identified for inclusion in the review. We discussed studies addressing or related to the issue of staging...

... and informed consent was obtained. Inclusion criteria were: a DSM-IV diagnosis of schizophrenia, schizophreniform disorder, bipolar disorder with psychotic features, schizoaffective disorder, psychosis not otherwise specified; age 18–35 in order to target young adults; smoking at least 3 joints of cannabis per...

... receptor sub-types in sleep, anxiety states, schizophrenia and depression. A summary of the relationship between these receptor sub-types and their possible involvement in the aetiology of schizophrenia, depression, anxiety and sleep disorders. 18 2 2010 © 1996 S. Karger AG, Basel 1996...

...Cinzia Bressi; Stefano Manenti; Patrizia Frongia; Matteo Porcellana; Giordano Invernizzi Background: Although evidence suggests the effectiveness of cognitive and behaviorally oriented family therapies for schizophrenia, no specific randomized study has been carried out on Systemic Family Therapy...

...Claire Daban; Anabel Martinez-Aran; Carla Torrent; Rafael Tabarés-Seisdedos; Vicent Balanzá-Martínez; Jose Salazar-Fraile; Gabriel Selva-Vera; Eduard Vieta Background: More and more epidemiological, genetic and neuroimaging studies show similarities between bipolar disorder (BD) and schizophrenia...

...Nicholas Tarrier Background: Schizophrenia and other psychotic disorders were once thought to be impervious to psychological treatments; however, there is accumulating evidence that cognitive behaviour therapy (CBT) can result in significant clinical benefit to these patients. Aim: This paper aims...

... in schizophrenia. As this possibility has been far less studied in bipolar disorder, we aimed to prospectively investigate the stability and specificity of cognitive performance in bipolar disorder compared to schizophrenia. Methods: Fifteen DSM-IV bipolar type I patients and 15 schizophrenic patients were...

...Inbar Nathans-Barel; Pablo Feldman; Barry Berger; Ilan Modai; Henry Silver Background: Anhedonia, a component of the negative symptom dimension and a core phenomenon in schizophrenia, is associated with poor social functioning and is resistant to treatment. We tested the hypothesis that animal...

...A. Martínez-Arán; R. Penadés; E. Vieta; F. Colom; M. Reinares; A. Benabarre; M. Salamero; C. Gastó Background: Recent studies have reported that differences in cognitive performance between schizophrenic and bipolar patients seem to be smaller than expected. Patients with schizophrenia have...

... analysis Autonomic nervous system Anxiety disorder Depression Schizophrenia Posttraumatic stress disorder Power spectrum analysis of heart rate variability (PSA of HRV) is a simple noninvasive method for quantifying the activity of the autonomic nervous system (ANS) control functions...